News

Mr Price will begin working at Cornerstone from September 8, 2008. He is currently serving as a managing director with Jefferies and leads its pharmaceutical services division. In

The acquisitions involve two facilities: Kenwood Surgery Center in Cincinnati, Ohio, and Ardmore Regional Surgery Center in Ardmore, Oklahoma. Combined, the centers have six operating rooms, one procedure

Prometheus said that this proprietary technology is used in the company’s Prometheus IBD serology 7 test and its recently launched Prometheus IBS diagnostic test. Prometheus has exclusive rights

Jinan Song, chairman and CEO of China-Biotics, said: “Square Pharmaceutical marks our fifth bulk additives customer, all of which have signed contracts before we begin production at our

PolyMedix received a notice of no objection from Health Canada for the company’s clinical trial application for PMX-30063 in May 2008. This first Phase I clinical trial will

The newly released secondary endpoint data extends clinical evidence that intravenous Dyloject offers safe, efficacious and well-tolerated pain relief for abdominal and pelvic surgery, the company said. Patient

Prior to joining the company as corporate controller in May 2008, Mr Henighan was vice president and corporate controller at HemoSense and corporate controller at Cholestech. Ron Bissinger,

The trial will evaluate Adentri, which is being developed under a licensing agreement with CV Therapeutics, or placebo in addition to standard of care in approximately 900 patients

Evexar Medical, in co-operation with University College London, has developed a technology to address endoleaks. The patented Evexar EndoSeal technology effectively seals gaps that can occur between an